- Home
- SPRU vs ANTX Comparison
SPRU vs ANTX Comparison
Compare SPRU & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SPRU
- ANTX
- Stock Information
- Founded
- SPRU 2008
- ANTX 2017
- Country
- SPRU United States
- ANTX United States
- Employees
- SPRU N/A
- ANTX N/A
- Industry
- SPRU Auto Parts:O.E.M.
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- SPRU Consumer Discretionary
- ANTX Health Care
- Exchange
- SPRU Nasdaq
- ANTX Nasdaq
- Market Cap
- SPRU 46.9M
- ANTX 37.6M
- IPO Year
- SPRU N/A
- ANTX 2022
- Fundamental
- Price
- SPRU $2.52
- ANTX $1.13
- Analyst Decision
- SPRU
- ANTX Hold
- Analyst Count
- SPRU 0
- ANTX 5
- Target Price
- SPRU N/A
- ANTX $3.50
- AVG Volume (30 Days)
- SPRU 24.6K
- ANTX 134.2K
- Earning Date
- SPRU 03-13-2025
- ANTX 03-27-2025
- Dividend Yield
- SPRU N/A
- ANTX N/A
- EPS Growth
- SPRU N/A
- ANTX N/A
- EPS
- SPRU N/A
- ANTX N/A
- Revenue
- SPRU $77,582,000.00
- ANTX N/A
- Revenue This Year
- SPRU $1.54
- ANTX N/A
- Revenue Next Year
- SPRU $3.40
- ANTX N/A
- P/E Ratio
- SPRU N/A
- ANTX N/A
- Revenue Growth
- SPRU N/A
- ANTX N/A
- 52 Week Low
- SPRU $2.17
- ANTX $0.87
- 52 Week High
- SPRU $4.89
- ANTX $3.88
- Technical
- Relative Strength Index (RSI)
- SPRU 39.94
- ANTX 44.20
- Support Level
- SPRU $2.44
- ANTX $1.09
- Resistance Level
- SPRU $2.65
- ANTX $1.20
- Average True Range (ATR)
- SPRU 0.12
- ANTX 0.05
- MACD
- SPRU 0.00
- ANTX 0.01
- Stochastic Oscillator
- SPRU 27.53
- ANTX 52.98
About SPRU Spruce Power Holding Corporation
Spruce Power Holding Corp is a leading owner and operator of distributed solar energy assets across the United States (the U.S.), offering subscription-based services to approximately 75,000 home solar assets and customer contracts, making renewable energy more accessible to everyone. The Company's primary customers are homeowners and the Company's core solar service offerings generate revenues primarily through (i) the sale of electricity generated by its home solar energy systems to homeowners, (ii) third-party contracts to sell solar renewable energy credits (SRECs) generated by the solar energy systems for fixed prices and (iii) the servicing of those agreements for other institutional owners of home solar energy systems.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease.